Use of Chk1 inhibitors to control cell proliferation

Details for Australian Patent Application No. 2004274013 (hide)

Owner ICOS Corporation

Inventors Weidner, Margaret; Clark, Darcey; Keegan, Kathleen S.; Peterson, Scott

Agent Wrays

Pub. Number AU-A-2004274013

PCT Pub. Number WO2005/027907

Priority 60/503,925 17.09.03 US

Filing date 17 September 2004

Wipo publication date 31 March 2005

International Classifications

A61K 31/4745 (2006.01)

A61K 31/513 (2006.01) - having oxo groups directly attached to the heterocyclic ring, e.g. cytosine

A61K 31/7048 (2006.01)

A61K 31/7068 (2006.01)

A61K 33/24 (2006.01) Medicinal preparations containing inorganic active ingredients - Heavy metals

A61P 35/00 (2006.01) Antineoplastic agents

A61P 43/00 (2006.01) Drugs for specific purposes, not provided for in groups

Event Publications

6 April 2006 PCT application entered the National Phase

  PCT publication WO2005/027907 Priority application(s): WO2005/027907

15 April 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004274016-Treatment of severe distal colitis

2004274008-Method and apparatus for treating diseased or fractured bone